Discover the future of pharmaceutical regulation with the European Pharmacopoeia’s new Certification of Suitability (CEP) 2.0.
Streamlining the certification process and enhancing transparency, CEP 2.0, launched in September 2023, is set to accelerate drug approvals and strengthen public health safeguards. It has been transforming the landscape for regulatory submissions and promises a more user-friendly approach, higher transparency, and the harmonization of quality standards. The result? A potential reduction in the time-to-market for drugs and an enhancement of public health protection.
Join Asphalion expert Enrique Solana, our Scientific & Regulatory Affairs Senior Officer, as he dives into:
- New certificate format – CEP 2.0
- New format – CEP 2.0
- Certificate versions co-existing: Old/Hybrid/2.0
- CMC updates with CEP 2.0
- How to achieve successful CEPs submissions
Register here: WEBINAR CERTIFICATE OF SUSTAINABILITY 2.0
For further information you can contact us at: [email protected]
